Reata Pharmaceuticals Price Prediction
| RETADelisted Stock | USD 109.67 3.31 2.93% |
Oversold Vs Overbought
65
Oversold | Overbought |
Using Reata Pharmaceuticals hype-based prediction, you can estimate the value of Reata Pharmaceuticals from the perspective of Reata Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Reata Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Reata because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Reata Pharmaceuticals after-hype prediction price | USD 109.67 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Reata |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Reata Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Reata Pharmaceuticals After-Hype Price Prediction Density Analysis
As far as predicting the price of Reata Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Reata Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Reata Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Reata Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Reata Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Reata Pharmaceuticals' historical news coverage. Reata Pharmaceuticals' after-hype downside and upside margins for the prediction period are 109.67 and 109.67, respectively. We have considered Reata Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Reata Pharmaceuticals is very steady at this time. Analysis and calculation of next after-hype price of Reata Pharmaceuticals is based on 3 months time horizon.
Reata Pharmaceuticals Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Reata Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Reata Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Reata Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 3 Events / Month | 8 Events / Month | In about 3 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
109.67 | 109.67 | 0.00 |
|
Reata Pharmaceuticals Hype Timeline
Reata Pharmaceuticals is at this time traded for 109.67. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Reata is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is at this time at 0.0%. %. The volatility of related hype on Reata Pharmaceuticals is about 0.0%, with the expected price after the next announcement by competition of 109.67. About 88.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 2.62. Reata Pharmaceuticals had not issued any dividends in recent years. Given the investment horizon of 90 days the next anticipated press release will be in about 3 days. Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.Reata Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Reata Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Reata Pharmaceuticals' future price movements. Getting to know how Reata Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Reata Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| SRPT | Sarepta Therapeutics | (4.04) | 11 per month | 0.00 | (0.27) | 2.28 | (3.10) | 9.65 | |
| MRTX | Mirati Ther | 0.00 | 0 per month | 0.00 | (0.17) | 4.02 | (4.07) | 16.13 | |
| KRYS | Krystal Biotech | 1.93 | 9 per month | 0.00 | (0.1) | 3.21 | (3.75) | 12.05 | |
| ICPT | Intercept Pharmaceuticals | 0.66 | 3 per month | 0.00 | (0.17) | 5.23 | (8.32) | 38.17 | |
| PTCT | PTC Therapeutics | (1.36) | 9 per month | 2.42 | 0.09 | 5.65 | (4.33) | 23.95 | |
| MDGL | Madrigal Pharmaceuticals | (3.37) | 10 per month | 2.17 | 0.08 | 4.92 | (3.96) | 30.27 | |
| CVAC | CureVac NV | (0.09) | 8 per month | 0.00 | (0.14) | 4.45 | (4.51) | 16.27 | |
| VIR | Vir Biotechnology | 0.05 | 8 per month | 0.00 | (0.08) | 5.41 | (5.81) | 35.87 | |
| PPCB | Propanc Biopharma | 0.00 | 0 per month | 10.58 | 0.01 | 33.33 | (25.00) | 58.33 | |
| VKTX | Viking Therapeutics | (0.26) | 10 per month | 0.00 | (0.06) | 6.24 | (8.05) | 34.61 | |
| TERN | Terns Pharmaceuticals | (0.02) | 10 per month | 0.00 | (0.1) | 5.68 | (5.96) | 34.09 | |
| AKRO | Akero Therapeutics | (1.61) | 7 per month | 2.68 | 0.06 | 5.23 | (4.45) | 13.37 |
Reata Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Reata price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Reata using various technical indicators. When you analyze Reata charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Reata Pharmaceuticals Predictive Indicators
The successful prediction of Reata Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Reata Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Reata Pharmaceuticals based on analysis of Reata Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Reata Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Reata Pharmaceuticals's related companies.
Story Coverage note for Reata Pharmaceuticals
The number of cover stories for Reata Pharmaceuticals depends on current market conditions and Reata Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Reata Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Reata Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Reata Pharmaceuticals Short Properties
Reata Pharmaceuticals' future price predictability will typically decrease when Reata Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Reata Pharmaceuticals often depends not only on the future outlook of the potential Reata Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Reata Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 36.3 M | |
| Cash And Short Term Investments | 387.5 M |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Consideration for investing in Reata Stock
If you are still planning to invest in Reata Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Reata Pharmaceuticals' history and understand the potential risks before investing.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |